Literature DB >> 1456394

Dyskeratosis congenita: clinical and genetic heterogeneity. Report of a new case and review of the literature.

R A Drachtman1, B P Alter.   

Abstract

Dyskeratosis congenita (DC) is a rare form of ectodermal dysplasia consisting of dystrophic nails, hyperpigmentation, and leukoplakia often associated with aplastic anemia. DC is considered to be an X-linked recessive trait, but affected females suggest genetic heterogeneity. We report an additional female with DC and review the world literature, indicating transmission in X-linked recessive, autosomal recessive, and autosomal dominant manners. The clinical and genetic aspects of DC are heterogeneous, and different patterns of inheritance are associated with distinct clinical manifestations. DC should be considered in the diagnosis of a patient with any features of the syndrome regardless of gender. Conversely, DC should be considered in patients with aplastic anemia at any age.

Entities:  

Mesh:

Year:  1992        PMID: 1456394

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  14 in total

1.  A boy with breathlessness, digital clubbing and central cyanosis.

Authors:  Sanne J Gordijn; Paul L P Brand
Journal:  Eur J Pediatr       Date:  2003-12-03       Impact factor: 3.183

2.  Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita.

Authors:  Mohamad M Al-Rahawan; Neelam Giri; Blanche P Alter
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

3.  Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita.

Authors:  K Devriendt; G Matthijs; E Legius; E Schollen; D Blockmans; C van Geet; H Degreef; J J Cassiman; J P Fryns
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

4.  Liver Transplantation After Bone Marrow Transplantation for End Stage Liver Disease with Severe Hepatopulmonary Syndrome in Dyskeratosis Congenita: A Literature First.

Authors:  Shyam Sunder Mahansaria; Senthil Kumar; Kishore G S Bharathy; Sachin Kumar; Viniyendra Pamecha
Journal:  J Clin Exp Hepatol       Date:  2015-11-12

5.  1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis.

Authors:  S W Knight; T J Vulliamy; N S Heiss; G Matthijs; K Devriendt; J M Connor; M D'Urso; A Poustka; P J Mason; I Dokal
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

6.  X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.

Authors:  S W Knight; N S Heiss; T J Vulliamy; S Greschner; G Stavrides; G S Pai; G Lestringant; N Varma; P J Mason; I Dokal; A Poustka
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

7.  Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita.

Authors:  Hinh Ly; Mike Schertzer; Wasil Jastaniah; Jeff Davis; Siu Li Yong; Qin Ouyang; Elizabeth H Blackburn; Tristram G Parslow; Peter M Lansdorp
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

8.  The effect of TERC haploinsufficiency on the inheritance of telomere length.

Authors:  Fred Goldman; Rachida Bouarich; Shashikant Kulkarni; Sara Freeman; Hong-Yan Du; Lea Harrington; Philip J Mason; Arturo Londoño-Vallejo; Monica Bessler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

Review 9.  Dyskeratosis congenita, stem cells and telomeres.

Authors:  Michael Kirwan; Inderjeet Dokal
Journal:  Biochim Biophys Acta       Date:  2009-02-07

Review 10.  The role of telomere biology in bone marrow failure and other disorders.

Authors:  Sharon A Savage; Blanche P Alter
Journal:  Mech Ageing Dev       Date:  2007-11-19       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.